India’s War on Questionable Pharmaceuticals In a significant move, the Indian government has banned 16 fixed-dose combination (FDC) medicines, citing concerns over their safety and therapeutic value. This decision, made by the Union Health Ministry, is part of a broader strategy to ensure that only scientifically validated and effective drugs reach the public. What’s intriguing here is the government’s proactive approach to drug regulation. By examining various drug combinations, they’ve identified those that are potentially harmful, therapeutically unjustified, or simply irrational. This raises a crucial question: how prevalent are these questionable drug combinations in the market, and what does it (Read more…)
Lesen Sie den vollständigen Artikel auf Papierkugel - All About Everything.